Medicinal Genomics
Randi Tarricone has extensive experience in customer support and patient advocacy within the biotechnology and education sectors. Currently serving as a Customer Support Specialist at Medicinal Genomics Corporation and Biofrontera Inc., Randi also holds the role of Senior Patient Advocate-Operations at Courtagen Life Sciences, Inc., where expertise in genetic testing for neurological disorders is applied to enhance treatment strategies for patients. Prior teaching experience includes positions at New Orleans Charter Science and Math High School and Kennett Consolidated School District. Randi holds a Bachelor of Arts degree in Political Sciences and Secondary Education from West Chester University of Pennsylvania.
This person is not in any offices
Medicinal Genomics
Medicinal Genomics is pioneering the genomics of medical cannabis and hemp. In 2011, Medicinal Genomics made worldwide headlines for being the first group to decode the Cannabis Genome. An increasing amount of scientific evidence supports the theory that cannabinoid compounds may have numerous medical benefits. Medicinal Genomics has the largestDNA sequence database of the cannabis plant and is well-positioned to design fingerprinting assays for strain genotyping and sequencing services for strain development. In 2011, Medicinal Genomics was acquired by Courtagen Life Sciences, Inc.